1. Medically reviewed by Daniel Murrell, M.D. — Written by Shannon Johnson on May 24, 2018. What to know about otomycosis.

2. Jimenez-Garcia, L., Celis-Aguilar, E., Díaz-Pavón, G., Muñoz Estrada, V., Castro-Urquizo, Á., Hernández-Castillo, N., & Amaro-Flores, E. (2019). Efficacy of topical clotrimazole vs. topical tolnaftate in the treatment of otomycosis. A randomized controlled clinical trial. Brazilian Journal of Otorhinolaryngology. doi:10.1016/j.bjorl.2018.12.007

3. Vega-Nava CT, Borrego-Montoya CR, Vásquez-Del Mercado E, Vega-Sánchez DC, Arenas R. Otitis externa de origen fúngico. Estudio de 36 pacientes en un hospital general. An Orl Mex. 2015;60:175---8.

4. Linstrom C, Lucente F. Diseases of the external ear. In: Bailey J, Johnson T, Newlands D, editors. Head & neck surgeryotolaryngology. Philadelphia, PA: Lippincott Williams & Wilkins; 2014. p. 1987---2002.

5. Rosenfeld RM, Brown L, Cannon CR, Dolor RJ, Ganiats TG, Hannley M, et al. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2006;134:S4---23.

6. Barati B, Okhovvat S, Goljanian A, Omrani M. Otomycosis in central Iran: a clinical and mycological study. Iran Red Crescent Med J. 2011;13:873---6.

7. Grunstein E, Santos F, Selesnick S. Trastornos de oído externo. In: Lawlani A, editor. Current Diagnóstico y tratamiento en Otorrinolaringología y cirugía de cabeza y cuello. New York, NY: McGraw Hill; 2009. p. 624---40.

8. Prasad SC, Kotigadde S, Shekhar M, Thada ND, Prabhu P, D’Souza T. Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification. Int J Microbiol. 2014;2014:1---9.

9. Pontes ZB, Silva AD, Lima E, Guerra M, Oliviera N, Carvalho M, et al. Otomycosis: a retrospective study. Braz J Otorhinolaryngol. 2009;75:367---70.

10. Moghadam AY, Asadi MA, Dehghani R, Mahmoudabadi AZ, Rayegan F, Hooshyar H, et al. Evaluating the effect of a mixture of alcohol and acetic acid for otomycosis therapy. Jundishapur J Microbiol. 2010;3:66---70.

11. Stern JC, Lucente FE. Otomycosis. Ear Nose Throat J. 1988;67:804---10.

12. Malik AA, Malik SN, Aslam MA, Rasheed D. Comparative efficacy of topical clotrimazole and 3% salicylic acid in otomycosis. Rawal Med J. 2012;13:46---9.

13. Ruz S, Breinbauer H, Corssen C. Otitis externa micótica y perforación timpánica: reporte de dos casos. Rev Otorrinolaringol Cir Cabeza Cuello. 2010;70:245---52.

14. Munguía R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008;72:453---9.

15. Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria. Mycoses. 2008;51:67---70.

16. Khan F, Muhammad R, Khan MR, Rehman F, Iqbal J, Khan M, et al. Efficacy of topical clotrimazole in treatment of otomycosis. J Ayub Med Coll Abbottabad. 2013;25:78---80.

17. Instituto Nacional de Estadística e Informática INEGI [INEGI website].

18. Wiswanta B, Naseerudddin Kh. Fungal infections of the ear in Immunocompromised host: a review. Mediterr J Hematol Infect Dis. 2011;3:e2011003.

19. Paulose KO, Al-Khalifa S, Shenoy P. Mycotic infection of the ear (otomycosis): a prospective study. J Laryngol Otol. 1989;103:3---5.

20. Ozcan MK, Ozcan M, Karaarslan A, Karaarslan F. Otomycosis in Turkey: predisposing factors, aetiology and therapy. J Laryngol Otol. 2003;117:39---42.

22. Nowrozi H, Arabi FD, Mehraban HG, Tavakoli A, Ghooshchi G. Mycological and clinical study of otomycosis in Tehran, Iran. Bull Environ Pharmacol Life Sci. 2014;3:29---

23. Kurnatowski P, Filipiak A. Otomycosis: prevalence, clinical symptoms, therapeutic procedure. Mycoses. 2001;44:472---9.

24. Mgbor N, Gugnani HC. Otomycosis in Nigeria: treatment with mercurochrome. Mycoses. 2001;44:395---7.

25. Hueso-Gutiérrez P, Jiménez-Alvarez S, Gil-Carcedo E, GilCarcedo L, Ramos-Sánchez C, Vallejo-Valdezate L. Presumed diagnosis: otomycosis. A study of 451 patients. Acta Otorrinolaryngol Esp. 2005;56:181---6.

26. Mishra GS, Mehta N, Pal M. Chronic bilateral otomycosis caused by aspergillus niger. Mycoses. 2004;47:82---4.

27. Araiza J, Canseco P, Bonifaz A. Otomycosis: clinical and mycological study of 97 cases. Rev Laryngol Otol Rhinol. 2006;127:251---4.

28. Kaur R, Mittal N, Kakkar M, Aggarwal AK, Mathur MD. Otomycosis: a clinicomycologic study. Ear Nose Throat J. 2000;79:606---9. 29. Jadhav VJ, Pai M, Mishra G. Etiological significance of Candida albicans in otitis externa. Mycopathologica. 2003;156:313---5.

29. Jackman A. Case report topical antibiotic induced otomycosis. Int J Pediatr Otorhinolaryngol. 2005;69:957---60.

30. Li Y, He L. Diagnosis and treatment of otomycosis in southern China. Mycoses. 2019;62(11):1064-1068.

31. Gharaghani M, Seifi Z, Zarei MA. Otomycosis in Iran: a review. Mycopathologia. 2015;179(5-6):415-424.

32. Koltsidopoulos P, Skoulakis C. Otomycosis with tympanic membrane perforation: a review of the literature [published online May 29, 2019]. Ear Nose Throat J. doi:10.1177/0145561319851499.

33. Punia RS, Singhal SK, Kundu R, Das A, Chander J. Fungal suppurative otitis media (histopathology) among patients in North India. Head Neck Pathol. 2019;13(2):149-153.

34. Arndal E, Glad H, Homøe P. Large discrepancies in otomycosis treatment in private ear, nose, and throat clinics in Denmark. Dan Med J. 2016;63(5):A5231.

35. Romsaithong S, Tomanakan K, Tangsawad W, Thanaviratananich S. Effectiveness of 3 per cent boric acid in 70 per cent alcohol versus 1 per cent clotrimazole solution in otomycosis patients: a randomised, controlled trial. J Laryngol Otol. 2016;130(9):811-815

36. Mofatteh MR, Naseripour YZ, Yousefi M, Namaei MH. Comparison of the recovery rate of otomycosis using betadine and clotrimazole topical treatment. Braz J Otorhinolaryngol. 2018;84(4):404-409.

37. Philip A, Thomas R, Job A, Sundaresan VR, Anandan S, Albert RR. Effectiveness of 7.5 percent povidone iodine in comparison to 1 percent clotrimazole with lignocaine in the treatment of otomycosis. ISRN Otolaryngol. 2013;2013:239730.

38. Anwar K, Gohar MS. Otomycosis; clinical features, predisposing factors and treatment implications. Pak J Med Sci. 2014;30(3):564-567.

39. Kiakojori K, Bagherpour JN, Khafri S, Mahdavi OS. Assessment of response to treatment in patients with otomycosis. Iran J Otorhinolaryngol. 2018;30(96):41-47.

40. Dundar R, İynen İ. Single dose topical application of clotrimazole for the treatment of otomycosis: is this enough? J Audiol Otol. 2019;23(1):15-19.

41. Zhang, S., Jin, M., Hu, S., Zhang, Y., & Zhou, G. (2020). Administration of 1% topical voriconazole drops was effective and safe in the treatment of refractory otomycosis without tympanic membrane perforation. Annals of Otology, Rhinology & Laryngology, 000348942094678. doi:10.1177/0003489420946783.

42. Treatment of otomycosis with acetic acid and boric acid otomikozun asetik as it ve borik asitle teda vis i. Mustafa erkan, tahsln asian, omit soyuer.

43. Stern JC, Lucente F : Otomycosis. Ear Nose Throat J 67:809-810,1988.

44. Stern JC, Shah MK, Lucente FE: In vitro effectiveness of 13 agents in otomycosis and review of the literature. Laryngoscope 98: 1173-1177, 1988.

45. Than KM, Kyaw SN, Myo M: Otomycosis in Burma, and its treatement. Am J Trop Med Hyg 29:620-623,1980.

21. Ghiacei S. Survey of otomycosis in north-western area of Iran. Med J Mashhad Uni Med Sci. 2001;43:85---7.